Prevalence of occult hepatitis C virus infection in Iranian patients with lymphoproliferative disorders

Journal of Medical Virology

Volumn 85, Issue 2, 2013, Pages 235-240

  Farahani, Maryam ^a   Bokharaei Salim, Farah ^b   Ghane, Masood ^c   Basi, Ali ^b   Meysami, Parisa ^b   Keyvani, Hossein ^b  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Hepatitis C virus; Lymphoproliferative disorders; Occult HCV infection; Peripheral blood mononuclear cells

Indexed keywords

VIRUS RNA;

5' UNTRANSLATED REGION; ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CROSS-SECTIONAL STUDY; FEMALE; GENE AMPLIFICATION; GENE SEQUENCE; GENOTYPE; HEPATITIS C; HUMAN; HUMAN CELL; IRAN; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; OCCULT HEPATITIS C; PERIPHERAL BLOOD MONONUCLEAR CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IRAN; LEUKOCYTES, MONONUCLEAR; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; RNA, VIRAL; YOUNG ADULT;

HEPATITIS C VIRUS;

EID: 84871102868     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23460     Document Type: Article

References (27)

1. Alavian SM. 2008. We need a new national approach to control hepatitis C: It is becoming too late. Hepatitis Monthly 8:165-169.
2. Alavian SM, Adibi P, Zali MR. 2005. Hepatitis C virus in Iran: Epidemiology of an emerging infection. Arch Iranian Med 8:84-90.
3. Barril G, Castillo I, Arenas MD, Espinosa M, Garcia-Valdecasas J, Garcia-Fernandez N, Gonzalez-Parra E, Alcazar JM, Sanchez C, Diez-Baylon JC, Martinez P, Bartolome J, Carreno V. 2008. Occult hepatitis C virus infection among hemodialysis patients. J Am Soc Nephrol 19:2288-2292.
4. Bartolome J, Lopez-Alcorocho JM, Castillo I, Rodriguez-Inigo E, Quiroga JA, Palacios R, Carreno V. 2007. Ultracentrifugation of serum samples allows detection of hepatitis C virus RNA in patients with occult hepatitis C. J Virol 81:7710-7715.
5. Bokharaei-Salim F, Keyvani H, Monavari SH, Alavian SM, Madjd Z, Toosi MN, Alizadeh AH. 2011. Occult hepatitis C virus infection in Iranian patients with cryptogenic liver disease. J Med Virol 83:989-995.
6. Bokharaei Salim F, Keyvani H, Amiri A, Jahanbakhsh Sefidi F, Shakeri R, Zamani F. 2010. Distribution of different hepatitis C virus genotypes in patients with hepatitis C virus infection. World J Gastroenterol 16:2005-2009.
7. Brown RS, Jr, Gaglio PJ. 2003. Scope of worldwide hepatitis C problem. Liver Transpl 9:S10-S13.
8. Castillo I, Bartolome J, Quiroga JA, Barril G, Carreno V. 2011. Long-term virological follow up of patients with occult hepatitis C virus infection. Liver Int 31:1519-1524.
9. Castillo I, Pardo M, Bartolome J, Ortiz-Movilla N, Rodriguez-Inigo E, de Lucas S, Salas C, Jimenez-Heffernan JA, Perez-Mota A, Graus J, Lopez-Alcorocho JM, Carreno V. 2004. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J Infect Dis 189:7-14.
10. Choo Q, Richman K, Han J, Berger K, Lee C, Dong C, Gallegos C, Coit D, Medina-Selby R, Barr P. 1991. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 88:2451-2455.
11. De Marco L, Gillio-Tos A, Fiano V, Ronco G, Krogh V, Palli D, Panico S, Tumino R, Vineis P, Merletti F, Richiardi L, Sacerdote C. 2009. Occult HCV infection: An unexpected finding in a population unselected for hepatic disease. PLoS ONE 4:e8128.
12. Ferri C, La Civita L, Longombardo G, Greco F, Bombardieri S. 1993. Hepatitis C virus and mixed cryoglobulinaemia. Eur J Clin Invest 23:399-405.
13. Ferri C, La Civita L, Zignego AL, Pasero G. 1997. Viruses and cancers: Possible role of hepatitis C virus. Eur J Clin Invest 27:711-718.
14. Idilman R, Colantoni A, De Maria N, Alkan S, Nand S, Van Thiel DH. 2004. Lymphoproliferative disorders in chronic hepatitis C. J Viral Hepat 11:302-309.
15. Kwok S, Higuchi R. 1989. Avoiding false positives with PCR. Nature 339:237-238.
16. Laskus T, Operskalski EA, Radkowski M, Wilkinson J, Mack WJ, deGiacomo M, Al-Harthi L, Chen Z, Xu J, Kovacs A. 2007. Negative-strand hepatitis C virus (HCV) RNA in peripheral blood mononuclear cells from anti-HCV-positive/HIV-infected women. J Infect Dis 195:124-133.
17. Martyak LA, Yeganeh M, Saab S. 2009. Hepatitis C and lymphoproliferative disorders: From mixed cryoglobulinemia to non-Hodgkin's lymphoma. Clin Gastroenterol Hepatol 7:900-905.
18. Merat S, Rezvan H, Nouraie M, Jafari E, Abolghasemi H, Radmard AR, Zaer-rezaii H, Amini-Kafiabad S, Maghsudlu M, Pourshams A, Malekzadeh R, Esmaili S. 2010. Seroprevalence of hepatitis C virus: The first population-based study from Iran. Int J Infect Dis 14:e113-e116.
19. Pardo M, Lopez-Alcorocho JM, Castillo I, Rodriguez-Inigo E, Perez-Mota A, Carreno V. 2006. Effect of anti-viral therapy for occult hepatitis C virus infection. Aliment Pharmacol Ther 23:1153-1159.
20. Paydas S, Kilic B, Sahin B, Bugdayci R. 1999. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders in Southern Turkey. Br J Cancer 80:1303-1305.
21. Pena LR, Nand S, De Maria N, Van Thiel DH. 2000. Hepatitis C virus infection and lymphoproliferative disorders. Dig Dis Sci 45:1854-1860.
22. Quiroga JA, Llorente S, Castillo I, Rodriguez-Inigo E, Pardo M, Carreno V. 2006. Cellular immune responses associated with occult hepatitis C virus infection of the liver. J Virol 80:10972-10979.
23. Schroter M, Feucht HH, Zollner B, Schafer P, Laufs R. 2003. Multiple infections with different HCV genotypes: Prevalence and clinical impact. J Clin Virol 27:200-204.
24. Schroter M, Zollner B, Schafer P, Laufs R, Feucht HH. 2001. Comparison of three HCV genotyping assays: A serological method as a reliable and inexpensive alternative to PCR based assays. J Clin Virol 23:57-63.
25. Thongsawat S, Maneekarn N, Kuniholm MH, Pantip C, Thungsuputi A, Lumlertkul D, Bannachak D, Nelson KE. 2008. Occult hepatitis C virus infection during an outbreak in a hemodialysis unit in Thailand. J Med Virol 80:808-815.
26. Zignego AL, Giannini C, Ferri C. 2007. Hepatitis C virus-related lymphoproliferative disorders: An overview. World J Gastroenterol 13:2467-2478.
27. Zignego AL, Macchia D, Monti M, Thiers V, Mazzetti M, Foschi M, Maggi E, Romagnani S, Gentilini P, Brechot C. 1992. Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol 15:382-386.